SHARK MONEYYACHT CLUBSearch Shark Money
Search public and private companies, people, funds, markets, tools, and research.
Venture capital database
Company formation · Pre-seed · Seed · Early stage
5AM Ventures
San Francisco, California, US
5AM Ventures focuses on Biopharmaceuticals, Drug delivery, Life-science tools and technologies across company formation through pre-seed through seed through early stage. Team and company relationships are indexed from official firm pages.
Strategy lens
Declared focus vs. observed sample
Declared focus reflects the firm’s own strategy language. Observed sectors summarize only the source-linked companies currently indexed here; it is not the firm’s complete portfolio allocation.
glycoengineering therapeutics1
in vivo hematopoietic stem-cell engineering1
intracellular therapeutics1
liquid-biopsy diagnostics1
radiopharmaceutical oncology1
regulatory-RNA therapeutics1
Founder fit screen
Prepare before contacting 5AM
Use the firm’s declared strategy and sourced relationship graph to build a specific outreach thesis. This is a preparation framework—not a claim about current appetite or check size.
Stage fit
Explain why the company belongs in Company formation, Pre-seed, Seed and what proof has already removed the prior stage’s risk.
Sector fit
Anchor the opportunity to Biopharmaceuticals, Drug delivery, Life-science tools and technologies. Name the specific market shift and why it is happening now.
Partner fit
Review 2 indexed team profiles. Address the partner whose operating history and portfolio context best match the company.
Portfolio context
Study the 6 source-linked companies shown here. State whether the company is complementary, differentiated, or potentially competitive.
Evidence packet
Bring customer proof, cohort or deployment metrics, gross-margin logic, capital use, key risks, and the milestone this financing should unlock.
Contact route
Use the firm’s public route and keep the request precise: company, stage, round, traction, why this firm, and one clear next step.
Key people
Official team source Who shapes the partnership
Managing Partner
Kush M. Parmar, M.D., Ph.D.
Managing Partner at 5AM Ventures, working in a firm focused on Biopharmaceuticals, Drug delivery, Life-science tools and technologies.
Founder and Managing Partner
Andrew J. Schwab
Founder and Managing Partner at 5AM Ventures, working in a firm focused on Biopharmaceuticals, Drug delivery, Life-science tools and technologies. Selected relationships
Official portfolio source Investments listed by the firm
regulatory-RNA therapeutics
Official sourceCAMP4 Therapeutics
Open the company graph to see founders and every indexed investor relationship.
in vivo hematopoietic stem-cell engineering
Official sourceEnsoma
Open the company graph to see founders and every indexed investor relationship.
intracellular therapeutics
Official sourceEntrada Therapeutics
Open the company graph to see founders and every indexed investor relationship.
glycoengineering therapeutics
Official sourceGlycoEra
Open the company graph to see founders and every indexed investor relationship.
liquid-biopsy diagnostics
Official sourcePrecede Biosciences
Open the company graph to see founders and every indexed investor relationship.
radiopharmaceutical oncology
Official sourceRadionetics Oncology
Open the company graph to see founders and every indexed investor relationship.
Help complete the graphClaim or improve
Claim or improve
5AM Ventures.
Founders, firm teams, investors, and careful researchers can submit a missing fact or correction. Every change enters a review queue and requires public evidence.
- No unsourced edits
- Identity and scope reviewed
- Existing claims retain history
Source discipline
This dossier uses publicly available firm pages for team, strategy, and portfolio context. It does not infer check size, ownership, valuation, current holding status, or availability for introductions.